Literature DB >> 9006713

Expression and localization of annexin V and annexin VI during limb bud formation in the rat fetus.

M M Rahman1, H Iida, Y Shibata.   

Abstract

We have investigated the expression and the localization of annexin V and annexin VI during the development of rat fetal limb buds by immunoblot and immunocytochemical analysis. Neither annexin V nor annexin VI was detectable in undifferentiated mesenchymal cells in limb buds of the day-13-day-16 rat fetus. Skeletal muscles, whose progenitor cells migrate from the somites and appeared in the limb buds at day 14, dramatically expressed annexin VI on the cell surface after differentiation from mononucleated myogenic cells into multinucleated myotubes. At day 16 both annexin V and annexin VI were found to be expressed in differentiated chondrocytes as well as in the perichondrium, a precursor of chondrocytes, whereas the compact layer of mesenchymal cells surrounding a chondrification center (precartilage) did not show any immunoreactivity for either of these proteins. The results suggest a close relationship between the expression of these annexins and cell differentiation of chondrocytes and skeletal muscles during limb but development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006713     DOI: 10.1007/s004290050022

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  4 in total

1.  Immunological development and cardiovascular function are normal in annexin VI null mutant mice.

Authors:  T E Hawkins; J Roes; D Rees; J Monkhouse; S E Moss
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Protein composition of the muscle mitochondrial reticulum during postnatal development.

Authors:  Yuho Kim; Daniel S Yang; Prasanna Katti; Brian Glancy
Journal:  J Physiol       Date:  2019-04-08       Impact factor: 5.182

3.  DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis.

Authors:  Timothy E Hawkins; Debipriya Das; Barry Young; Stephen E Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy.

Authors:  Fan Qiu; Minjin Hu; Bo Tang; Xiufeng Liu; Hongqin Zhuang; Jie Yang; Zi-Chun Hua
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.